The successful development of innovative pharmaceutical technologies requires a seamless integration of manufacturing design with regulatory and clinical strategy. This presentation explores the critical components involved in designing a development and manufacturing plan for new drug products and delivery systems, including aspects on Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), and the Target Product Profile (TPP). It will highlight how early alignment of these elements ensures quality, safety, and scalability—while directly influencing the efficiency and structure of clinical trials and commercial manufacturing. The focus will be on oral solid drug products.
This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.
The expert-panel discussion educated me in strategic and meritorious choice of inventions to approach investors and manage investment funds for establishing a spin off.
Ram Siddappa
Erasmus MC, Netherlands
From day one ASTP has been a tremendous help. Learning throughs seminars and workshops or meeting peers for discussions, there is always someone around to exchange ideas with.
Paul van Dun
KU Leuven, Belgium
Organisation and speakers were great, so enthusiastic about their work and very good at transferring their knowledge.
Sarka Bartova
Research Centre Rez, Czech Republic
Most experienced technology transfer crew in the Europe.
Krzysztof Maternicki
Jan Dlugosz University, Poland
I strongly recommend the course, even if you are not going to set-up an office but you are part of the team that wants to change or improve how technology transfer is done at your institution.
Ricardo Castro
Centre for research in agricultural Genomics, Spain
Join our newsletter and get the latest news